Telmisartan + amlodipine

DRUG2 trials

Sponsors

Boehringer Ingelheim, Daewon Pharmaceutical Co., Ltd.

Conditions

DyslipidemiaHypertension

Phase 3

Add-on to Micamlo BP Trial

CompletedNCT01975246

Boehringer IngelheimHypertension

Start: 2013-11-30End: 2014-07-31Updated: 2016-11-29

Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia

CompletedNCT03210532

Daewon Pharmaceutical Co., Ltd.Dyslipidemia, Hypertension

Start: 2016-10-07End: 2017-09-30Updated: 2018-02-01